Dong-A Pharm Chairman accepts FKI's acting chief

Published: 2003-11-17 06:59:00

Updated: 2003-11-17 06:59:00

Kang Shin-ho, chairman of Dong-A Pharm, accepted an offer to serve as the acting chief of the Federation of Korean Industries during a meeting of its member companies' leaders on November 12.

The federation offered him its top post on October 30, when his predecessor, SK Group Chairman, Son Ki...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK